These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 53069

  • 1. On the interaction of 3,4,5,6-tetrahydrouridine with human liver cytidine deaminase.
    Wentworth DF, Wolfenden R.
    Biochemistry; 1975 Nov 18; 14(23):5099-105. PubMed ID: 53069
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of Escherichia coli cytidine deaminase by a phosphapyrimidine nucleoside.
    Ashley GW, Bartlett PA.
    J Biol Chem; 1984 Nov 10; 259(21):13621-7. PubMed ID: 6386818
    [Abstract] [Full Text] [Related]

  • 3. Analysis of cytidine deaminase and tetrahydrouridine interaction by use of ligand techniques.
    Stoller RG, Myers CE, Chabner BA.
    Biochem Pharmacol; 1978 Jan 01; 27(1):53-9. PubMed ID: 619907
    [No Abstract] [Full Text] [Related]

  • 4. Deoxycytidine transport in the presence of a cytidine deaminase inhibitor and the transport of uracil in Escherichia coli B.
    von Dippe PJ, Leung K, Roy-Burman S, Visser DW.
    J Biol Chem; 1975 May 25; 250(10):3666-71. PubMed ID: 1092677
    [Abstract] [Full Text] [Related]

  • 5. Epimer interconversion, isomerization, and hydrolysis of tetrahydrouridine: implications for cytidine deaminase inhibition.
    Xiang TX, Niemi R, Bummer P, Anderson BD.
    J Pharm Sci; 2003 Oct 25; 92(10):2027-39. PubMed ID: 14502542
    [Abstract] [Full Text] [Related]

  • 6. The action of bacterial cytidine deaminase on 5,6-dihydrocytidine.
    Evans BE, Mitchell GN, Wolfenden R.
    Biochemistry; 1975 Feb 11; 14(3):621-4. PubMed ID: 1090298
    [Abstract] [Full Text] [Related]

  • 7. Use of 5-trifluoromethyldeoxycytidine and tetrahydrouridine to circumvent catabolism and exploit high levels of cytidine deaminase in tumors to achieve DNA- and target-directed therapies.
    Mekras JA, Boothman DA, Greer SB.
    Cancer Res; 1985 Nov 11; 45(11 Pt 1):5270-80. PubMed ID: 2932216
    [Abstract] [Full Text] [Related]

  • 8. Furanose-pyranose isomerization of reduced pyrimidine and cyclic urea ribosides.
    Kelley JA, Driscoll JS, McCormack JJ, Roth JS, Marquez VE.
    J Med Chem; 1986 Nov 11; 29(11):2351-8. PubMed ID: 3783592
    [Abstract] [Full Text] [Related]

  • 9. Comparative studies of the cytostatic action and metabolism of 5-azacytidine and 5,6-dihydro-5-azacytidine.
    Voytek P, Beisler JA, Abbasi MM, Wolpert-DeFilippes MK.
    Cancer Res; 1977 Jul 11; 37(7 Pt 1):1956-61. PubMed ID: 67884
    [Abstract] [Full Text] [Related]

  • 10. Tetrahydrouridine, cytidine analogues, and hemoglobin F.
    DeSimone J, Heller P, Molokie RE, Hall L, Zwiers D.
    Am J Hematol; 1985 Mar 11; 18(3):283-8. PubMed ID: 2579548
    [Abstract] [Full Text] [Related]

  • 11. Modulation of the effect of 1-beta-D-arabinofuranosylcytosine based on changes of cytidine deaminase activity in HL60 cells.
    Mejer JN, Mortensen BT, Christensen IJ.
    Med Oncol Tumor Pharmacother; 1990 Mar 11; 7(1):25-9. PubMed ID: 2338846
    [Abstract] [Full Text] [Related]

  • 12. Potent inhibitors for the deamination of cytosine arabinoside and 5-aza-2'-deoxycytidine by human cytidine deaminase.
    Laliberté J, Marquez VE, Momparler RL.
    Cancer Chemother Pharmacol; 1992 Mar 11; 30(1):7-11. PubMed ID: 1375134
    [Abstract] [Full Text] [Related]

  • 13. Synthesis of pyrimidin-2-one nucleosides as acid-stable inhibitors of cytidine deaminase.
    Kim CH, Marquez VE, Mao DT, Haines DR, McCormack JJ.
    J Med Chem; 1986 Aug 11; 29(8):1374-80. PubMed ID: 3735306
    [Abstract] [Full Text] [Related]

  • 14. Mechanism for ara-CTP catabolism in human leukemic cells and effect of deaminase inhibitors on this process.
    Fridland A, Verhoef V.
    Semin Oncol; 1987 Jun 11; 14(2 Suppl 1):262-8. PubMed ID: 3035721
    [No Abstract] [Full Text] [Related]

  • 15. Metabolic channeling of 5-fluoro-2'-deoxycytidine utilizing inhibitors of its deamination in cell culture.
    Boothman DA, Briggle TV, Greer S.
    Mol Pharmacol; 1985 May 11; 27(5):584-94. PubMed ID: 2581125
    [Abstract] [Full Text] [Related]

  • 16. Design, synthesis, and pharmacological evaluation of fluorinated tetrahydrouridine derivatives as inhibitors of cytidine deaminase.
    Ferraris D, Duvall B, Delahanty G, Mistry B, Alt J, Rojas C, Rowbottom C, Sanders K, Schuck E, Huang KC, Redkar S, Slusher BB, Tsukamoto T.
    J Med Chem; 2014 Mar 27; 57(6):2582-8. PubMed ID: 24520856
    [Abstract] [Full Text] [Related]

  • 17. Effect of tetrahydrouridine on metabolism and transport of 1-beta-D-arabinofuranosylcytosine in human cells.
    Riva C, Barra Y, Carcassonne Y, Cano JP, Rustum Y.
    Chemotherapy; 1992 Mar 27; 38(5):358-66. PubMed ID: 1286578
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of cytidine deaminase by 2-oxopyrimidine riboside and related compounds.
    McCormack JJ, Marquez VE, Liu PS, Vistica DT, Driscoll JS.
    Biochem Pharmacol; 1980 Mar 01; 29(5):830-2. PubMed ID: 20227965
    [No Abstract] [Full Text] [Related]

  • 19. Influence of tetrahydrouridine on the phosphorylation of 1-beta-D-arabinofuranosyl-cytosine (ara-C) by enzymes from solid tumors in vitro.
    Furner RL, Mellett LB, Herren TC.
    J Pharmacol Exp Ther; 1975 Jul 01; 194(1):103-10. PubMed ID: 1057009
    [Abstract] [Full Text] [Related]

  • 20. Cytidine and deoxycytidylate deaminase inhibition by uridine analogs.
    Drake JC, Hande KR, Fuller RW, Chabner BA.
    Biochem Pharmacol; 1980 Mar 01; 29(5):807-11. PubMed ID: 20227960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.